Skip to content
10-K

Annual Report

DAY ONE BIOPHARMACEUTICALS, INC.

0001193125-26-066956

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 103.3M sh
Shares Diluted FY 2025 · Dec 31, 2025 103.21M sh
Capex FY 2025 · Dec 31, 2025 $320K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$103.76M
Short Term Investments FY 2025 · Dec 31, 2025 $244.04M
Cash And Equivalents FY 2025 · Dec 31, 2025 $197.08M
Stockholders Equity FY 2025 · Dec 31, 2025 $441.16M
Current Liabilities FY 2025 · Dec 31, 2025 $60.52M
Total Liabilities FY 2025 · Dec 31, 2025 $66.67M
Current Assets FY 2025 · Dec 31, 2025 $485.1M
Total Assets FY 2025 · Dec 31, 2025 $507.83M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.04
Eps Basic FY 2025 · Dec 31, 2025 −$1.04
Sga Expense FY 2025 · Dec 31, 2025 $120.59M
Rd Expense FY 2025 · Dec 31, 2025 $148.14M
Operating Income FY 2025 · Dec 31, 2025 −$127.75M
Revenue FY 2025 · Dec 31, 2025 $158.18M